comprehensive -WSS

comprehensive

author：explore 2025-09-30 21:22:18 - browse：51

Biogen announced a new round of cost cuts Tuesday, saying that it plans to save $700 million in operating costs and cut 1,000 jobs by 2025.

The company also released second quarter sales and earnings that handily topped the forecasts of Wall Street analysts. In early morning trading, Biogen shares rose more than 1%.

Biogen is attempting to recover from a series of corporate stumbles, the biggest of which involved the development and launch of the Alzheimer’s drug Aduhelm. The medicine was the first of a new class of disease-modifying Alzheimer’s drugs to be approved by the Food and Drug Administration. But doubts about the quality of the data behind the medicine meant that Medicare wouldn’t pay for it and doctors did not prescribe it. The resulting financial disaster cleaned out Biogen’s executive suite.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： FDA needs staff influx to meet gene therapy needs, Marks says

explore

WSS

How CRISPR works, explained in two minutes

Sage considers ways to reduce costs following FDA rejection

Pharma patents targeted by Biden in move to slash drug prices

St. Louis police protesters begin picking up checks in $4.9 million settlement

Congenital heart disease patients face new threat of heart failure

How CRISPR works, explained in two minutes

hotspot

comprehensive

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

What PEPFAR has meant on the ground in Ukraine

Medicare proposal to cover medical devices draws a mixed reaction

Many breast cancer patients receive more radiation than needed

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Chemotherapy shortages won’t get better under Biden’s latest plan

Virginia high school admissions case could be legal follow

Doctors push to include dialysis machines in emergency stockpile

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Feed a cold, starve a fever? Here’s what science says

focus

How CRISPR works, explained in two minutes

Pregnancy discrimination could be enabled by AI

Teach medical students about patients with intellectual disabilities

STAT letters to the editor on burnt

Spinal cord stimulation reduces pain in amputees, study finds

AI models in health care face new federal disclosure requirements

entertainment

hotspot

explore

knowledge